financetom
Business
financetom
/
Business
/
EU weighs pausing parts of landmark AI act in face of US and big tech pressure, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU weighs pausing parts of landmark AI act in face of US and big tech pressure, FT reports
Nov 6, 2025 10:51 PM

Nov 7 (Reuters) - The European Commission is proposing

to pause parts of its landmark artificial intelligence (AI)

legislation amid intense pressure from big tech companies and

the U.S. government, the Financial Times reported on Friday.

The move follows months of urging by tech giants like Meta

and Alphabet, and pressure from the Trump

administration, which has warned against measures that could

provoke trade tensions.

The EU has been "engaging" with the Trump administration

on adjustments to the AI act and other digital regulations as

part of a wider simplification process, which is due to be

adopted on November 19, a senior EU official told the FT.

Reuters could not immediately verify the report. The EU

did not immediately respond to Reuters requests for comment.

In July, a

spokesperson

for the European Commission dismissed calls from some

companies and countries for a pause, saying the AI rules would

be rolled out according to the legal timeline in the

legislation.

Talks were continuing within the commission regarding

potential delays to "the implementation of targeted parts of the

AI act," a spokesperson for the EU told the FT. They added that

while various options were being considered, the EU remained

"fully behind the AI act and its objectives."

The legislation came into force in August 2024 but many

of the provisions are staggered to come into effect in coming

years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
J.M. Smucker Fiscal Q4 Adjusted Earnings, Sales Decline; Fiscal 2026 Outlook Cut -- Shares Slump
J.M. Smucker Fiscal Q4 Adjusted Earnings, Sales Decline; Fiscal 2026 Outlook Cut -- Shares Slump
Jun 10, 2025
07:32 AM EDT, 06/10/2025 (MT Newswires) -- J.M. Smucker (SJM) reported fiscal Q4 adjusted earnings Tuesday of $2.31 per diluted share, down from $2.66 a year earlier. Analysts surveyed by FactSet expected $2.24. Net sales for the quarter ended April 30 declined to $2.14 billion, down from $2.21 billion last year. Analysts polled by FactSet expected $2.18 billion. The company...
US FDA approves Merck's RSV antibody for infants
US FDA approves Merck's RSV antibody for infants
Jun 10, 2025
(Reuters) -The U.S. Food and Drug Administration on Monday approved Merck's ( MRK ) preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the company said. Merck's ( MRK ) monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
MediPharm Labs Co-founder, Former CEO Joins Apollo Capital in Contesting Management
MediPharm Labs Co-founder, Former CEO Joins Apollo Capital in Contesting Management
Jun 10, 2025
07:36 AM EDT, 06/10/2025 (MT Newswires) -- MediPharm Labs ( MEDIF ) co-founder and former chief executive, Pat McCutcheon, has joined Apollo Capital in contesting management, the investment fund said late on Monday. McCutchen said MediPharm's ( MEDIF ) share price has collapsed over the past three years while senior management has been paid more than $10 million even as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved